Hjem › Atopisk dermatitis (eczem) › Illinois
Atopisk dermatitis (eczem) kliniske forsøg i Illinois
10 studier for Atopisk dermatitis (eczem) søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029, Normal
- Rosalind Franklin University of Medicine and Science- Site Number: 8400056, North Chicago
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Chicago
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Skokie
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Endeavor Health, Skokie
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 2, Rolling Meadows
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Northwestern University Feinberg School of Medicine /ID# 265117, Chicago
- Sneeze Wheeze & Itch Associates /ID# 267238, Normal
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 6. aug. 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- DeNova Research /ID# 264513, Chicago
- Northwestern University Feinberg School of Medicine /ID# 264983, Chicago
RekruttererFase 3
Alder 18 til 63 · Alle køn · Opdateret 6. jul. 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Northwestern University Feinberg School of Medicine: Department of Dermatology, Chicago
RekruttererFase 1
Alder 6 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT06504160Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Lurie Children's Hospital/Northwestern University, Chicago
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. apr. 2026 · NCT05042258Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7058, Chicago
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT06988605Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.